NEJM This Week — April 6, 2023
Featuring articles on thrombectomy for large ischemic strokes, CAR T cells for relapsed or refractory neuroblastoma, postexposure doxycycline to prevent bacterial STIs, and the genetic risk of low-grade glioma; a review article on primary Budd–Chiari syndrome; a Clinical Problem-Solving on an alternate explanation; and Perspective articles on ensuring public trust in an empowered FDA, on why diverse clinical trial participation matters, and on a quixotic quest for independence.
